CompletedNCT02072954
Comparison of Two Asenapine Tablet Products in People With Schizophrenia
About this title
Read the official source — NCT02072954Medication studyAges 18–65India
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Jūnāgadh and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateNovember 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 48
- Sponsor
- Amneal Pharmaceuticals, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- India
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02072954
- Official title
Show the full official title
A Multicentric, Open Label, Randomized, Balanced, Two Treatment, Three Period, Three Sequence, Crossover, Multiple Dose, Steady State Bioequivalence Study of Asenapine Sublingual Tablets, 10 mg Manufactured by AMNEAL PHARMACEUTICALS, USA With Reference Product SAPHRIS® (Asenapine) Sublingual Tablets, 10 mg Manufactured by Catalent UK Swindon Zydis Ltd., Blagrove, Swindon, Wiltshire, SN5 8RU, UK; Distributed by Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, 08889, USA in Adult Human Male & Female Patients Under Fasting Condition.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Jūnāgadh · Surat
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Amneal Pharmaceuticals, LLC.
Did this study involve medication?
Yes. The study involved medication, including Asenapine Sublingual Tablets 10 mg.
Who was this study for?
Listed age limits: 18 years to 65 years.
